Alivus Life Sciences Statistics

Total Valuation

BOM:543322 has a market cap or net worth of INR 126.16 billion. The enterprise value is 121.24 billion.

Market Cap	126.16B
Enterprise Value	121.24B

Important Dates

The next estimated earnings date is Wednesday, July 23, 2025.

Earnings Date	Jul 23, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	122.63M
Shares Outstanding	n/a
Shares Change (YoY)	+0.16%
Shares Change (QoQ)	-0.09%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	30.73M

Valuation Ratios

The trailing PE ratio is 25.98 and the forward PE ratio is 23.20.

PE Ratio	25.98
Forward PE	23.20
PS Ratio	5.29
PB Ratio	4.48
P/TBV Ratio	4.51
P/FCF Ratio	55.99
P/OCF Ratio	32.22
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 17.76, with an EV/FCF ratio of 53.80.

EV / Earnings	24.97
EV / Sales	5.08
EV / EBITDA	17.76
EV / EBIT	19.49
EV / FCF	53.80

Financial Position

The company has a current ratio of 4.97, with a Debt / Equity ratio of 0.02.

Current Ratio	4.97
Quick Ratio	3.23
Debt / Equity	0.02
Debt / EBITDA	0.08
Debt / FCF	0.25
Interest Coverage	257.65

Financial Efficiency

Return on equity (ROE) is 18.86% and return on invested capital (ROIC) is 14.88%.

Return on Equity (ROE)	18.86%
Return on Assets (ROA)	12.42%
Return on Invested Capital (ROIC)	14.88%
Return on Capital Employed (ROCE)	21.15%
Revenue Per Employee	11.85M
Profits Per Employee	2.41M
Employee Count	2,014
Asset Turnover	0.76
Inventory Turnover	1.61

Taxes

In the past 12 months, BOM:543322 has paid 1.69 billion in taxes.

Income Tax	1.69B
Effective Tax Rate	25.76%

Stock Price Statistics

The stock price has increased by +16.13% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+16.13%
50-Day Moving Average	1,060.05
200-Day Moving Average	1,076.70
Relative Strength Index (RSI)	43.50
Average Volume (20 Days)	5,083

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BOM:543322 had revenue of INR 23.87 billion and earned 4.86 billion in profits. Earnings per share was 39.52.

Revenue	23.87B
Gross Profit	13.06B
Operating Income	6.22B
Pretax Income	6.54B
Net Income	4.86B
EBITDA	6.83B
EBIT	6.22B
Earnings Per Share (EPS)	39.52

Full Income Statement

Balance Sheet

The company has 5.49 billion in cash and 566.06 million in debt, giving a net cash position of 4.92 billion.

Cash & Cash Equivalents	5.49B
Total Debt	566.06M
Net Cash	4.92B
Net Cash Per Share	n/a
Equity (Book Value)	28.17B
Book Value Per Share	229.77
Working Capital	18.65B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 3.92 billion and capital expenditures -1.66 billion, giving a free cash flow of 2.25 billion.

Operating Cash Flow	3.92B
Capital Expenditures	-1.66B
Free Cash Flow	2.25B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 54.72%, with operating and profit margins of 26.06% and 20.35%.

Gross Margin	54.72%
Operating Margin	26.06%
Pretax Margin	27.41%
Profit Margin	20.35%
EBITDA Margin	28.60%
EBIT Margin	26.06%
FCF Margin	9.44%

Dividends & Yields

BOM:543322 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.16%
Shareholder Yield	n/a
Earnings Yield	3.85%
FCF Yield	1.79%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	5